Cresco Labs Inc. (CRLBF) Price to Sales (2020 - 2026)

Cresco Labs (CRLBF) has reported Price to Sales for 7 consecutive years, with 122.23 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 53.62% year-over-year to 122.23; the trailing twelve-month figure through Jun 2026 stood at 32.54 (up 71.23% YoY), and the FY2025 full-year result was 47.88, up 49.28% from the prior year.
• Price to Sales fell to 122.23 in Q2 2026 per CRLBF's latest filing, from 146.77 in the prior quarter.
• Across five years, Price to Sales topped out at 661.86 in Q1 2022 and bottomed at 79.57 in Q2 2025.
• Historically, Price to Sales has averaged 225.25 across 5 years, with a median of 204.04 in 2023.
• The sharpest annual moves came in 2022 and 2026: Price to Sales sank 78.26% in 2022, then jumped 53.62% in 2026.
• Over 5 years, Price to Sales stood at 230.24 in 2022, then declined by 19.89% to 184.44 in 2023, then retreated by 28.4% to 132.06 in 2024, then jumped by 47.18% to 194.36 in 2025, then plunged by 37.11% to 122.23 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 122.23, 146.77, and 194.36 for Q2 2026, Q1 2026, and Q4 2025 respectively.